Nigeria
Tuberculosis profile
| High TB burden | High HIV burden | High MDR-TB burden |
Population  2012 169 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 27 (1.6–86) 16 (0.92–51)
Mortality (HIV+TB only) 19 (11–25) 11 (6.7–15)
Prevalence  (includes HIV+TB) 270 (43–710) 161 (25–420)
Incidence  (includes HIV+TB) 180 (85–310) 108 (50–186)
Incidence (HIV+TB only) 46 (21–80) 27 (13–47)
Case detection, all forms (%) 51 (29–110)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 52 901 (59) Relapse 2 513 (33)
Smear-negative 32 972 (37) Treatment after failure 612 (8)
Smear-unknown / not done     Treatment after default 1 174 (16)
Extrapulmonary 4 432 (5) Other 3 249 (43)
Other          
Total new 90 305   Total retreatment 7 548  
           
Other (history unknown)          
Total new and relapse 92 818   Total cases notified 97 853  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 1.6    
Age < 15 1 187 3 950 740
Laboratories 2012
Smear (per 100 000 population) 0.8
Culture (per 5 million population) 0.1
Drug susceptibility testing (per 5 million population) <0.1
Is second-line drug susceptibility testing available? Yes, outside
country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 85   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 85  
Retreatment 82  
TB/HIV 2012 Number (%)
TB patients with known HIV status 82 641 (84)
HIV-positive TB patients 19 342 (23)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 15 565 (80)
HIV-positive TB patients on antiretroviral therapy (ART) 10 866 (56)
HIV-positive people screened for TB 140 460  
HIV-positive people provided with IPT 2 257  
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 2.9 (2.1–4) 14 (10–19)
MDR-TB cases among notified pulmonary
TB cases
2 500 (1 800–3 400) 1 100 (770–1 500)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 11 (<1%) 94 (1%) 107
Laboratory-confirmed MDR-TB cases 11 94 107
Patients started on MDR-TB treatment     125
Financing TB control 2013
National TB programme budget (US$ millions) 151
% Funded domestically 8%
% Funded internationally 25%
% Unfunded 68%
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

Total budget (US$ millions)
Budget funding Graph
__ Funded domestically __ Funded internationally
__ Unfunded
 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-25 Data: www.who.int/tb/data